Evidence map›Paper›PMID 38657186›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Reply to S. Zhang et al and S. Selukar.

Nathaniel S O'Connell

Abstract readLetterComment
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Nathaniel S O'ConnellNathaniel S. O'Connell, PhD, Wake Forest University School of Medicine, Winston-Salem, NC.

Funding

Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)U01CA233169 · NCI · DANA-FARBER CANCER INST · PI GRAY, ROBERT J, WAGNER, LYNNE I. · 2018 to 2023
$3.4M
NCI NIH HHS U01 CA233169
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38657186
PMCPMC11477063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.